These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 5480261

  • 1. [Effect of benzbromarone on serum uric acid level and uric acid excretion of patients with gout].
    Zöllner N, Griebsch A, Fink JK.
    Dtsch Med Wochenschr; 1970 Nov 27; 95(48):2405-12. PubMed ID: 5480261
    [No Abstract] [Full Text] [Related]

  • 2. [Benziodarone in the basic treatment of gout].
    Ryckewaert A, Puel M, Kuntz D.
    Rev Rhum Mal Osteoartic; 1972 Jan 27; 39(1):33-9. PubMed ID: 5079688
    [No Abstract] [Full Text] [Related]

  • 3. [The effect of benzbromaron in gout patients with limited kidney function].
    Kuzmits R, Bresnik W, Müller MM.
    Fortschr Med; 1979 Nov 22; 97(44):2057-61. PubMed ID: 511087
    [Abstract] [Full Text] [Related]

  • 4. Influence of urate-lowering therapies on renal handling of uric acid.
    Ma L, Wei L, Chen H, Zhang Z, Yu Q, Ji Z, Jiang L.
    Clin Rheumatol; 2016 Jan 22; 35(1):133-41. PubMed ID: 25373449
    [Abstract] [Full Text] [Related]

  • 5. Effect of single oral doses of benzbromarone on serum and urinary uric acid.
    Jain AK, Ryan JR, McMahon FG, Noveck RJ.
    Arthritis Rheum; 1974 Jan 22; 17(2):149-57. PubMed ID: 4814978
    [No Abstract] [Full Text] [Related]

  • 6. [Changes in the serum concentration of uric acid under the effect of benzbromaronum].
    Mertz DP.
    Munch Med Wochenschr; 1969 Feb 28; 111(9):491-5. PubMed ID: 5818966
    [No Abstract] [Full Text] [Related]

  • 7. [Effect of benziodarone on hyperuricemia due to fasting].
    Fellin R, Pagnan A, Fedele D, Novello M, Crepaldi G.
    Policlinico Med; 1972 Feb 28; 79(3):151-64. PubMed ID: 5051107
    [No Abstract] [Full Text] [Related]

  • 8. Uricosuric effect of irtemazole in hyperuricemic patients without and with renal insufficiency.
    Kamilli I, Gresser U, Pellkofer T, Löffler W, Zöllner N.
    Z Rheumatol; 1989 Feb 28; 48(6):307-12. PubMed ID: 2623976
    [Abstract] [Full Text] [Related]

  • 9. The pharmacology of hypouricemic effect of benzbromarone.
    Sinclair DS, Fox IH.
    J Rheumatol; 1975 Dec 28; 2(4):437-45. PubMed ID: 1206675
    [Abstract] [Full Text] [Related]

  • 10. [Gout treatment with a dibromine derivative of benzofuran].
    Delbarre F, Auscher C, Saporta L, de Grey A, Danchot J.
    Rev Rhum Mal Osteoartic; 1973 Apr 28; 40(4):275-7. PubMed ID: 4716906
    [No Abstract] [Full Text] [Related]

  • 11. [Serum uric acid and uric acid elimination after benzbromarone therapy in patients with gout and hyperuricemia].
    Matzkies F, Neuwirth R, Berg G.
    Fortschr Med; 1976 Sep 16; 94(26):1427-9. PubMed ID: 976920
    [Abstract] [Full Text] [Related]

  • 12. [Study of the effects of benziodarone in 100 gouty patients during a diuresis cure: effects on uric acid and oxalic acid].
    Mugler A.
    Rein Foie; 1967 Sep 16; 10():273-92. PubMed ID: 6081455
    [No Abstract] [Full Text] [Related]

  • 13. [Treatment of hyperuricemia with benziodarone].
    Ravault PP, Vignon G, Lejeune E, Bouvier M, Queneau P.
    Presse Therm Clim; 1970 Sep 16; 107(2):74-9. PubMed ID: 5468122
    [No Abstract] [Full Text] [Related]

  • 14. [Benziodarone in the treatment of primary hyperuricemias].
    Bianco G, Marcolongo R, Carcassi A.
    Minerva Med; 1968 Dec 12; 59(99):5470-81. PubMed ID: 5718835
    [No Abstract] [Full Text] [Related]

  • 15. [Analysis of the hypo-uricemic action of benzbromarone in 40 cases of gouty and non-gouty hyperuricemia].
    Famaey JP, Vandenabeele G.
    J Belge Rhumatol Med Phys; 1970 Dec 12; 25(1):5-9. PubMed ID: 5486285
    [No Abstract] [Full Text] [Related]

  • 16. [Therapy with alllopurinol and benzbromarone, single and combined. Renal elimination of lithogenous and colloid protective substances (author's transl)].
    Mertz DP.
    Med Klin; 1977 Apr 15; 72(15):664-8. PubMed ID: 857138
    [Abstract] [Full Text] [Related]

  • 17. [Uricosuric effect of a phenylbutazone derivative, cetophenylbutazone].
    Mugler A.
    Rev Rhum Mal Osteoartic; 1971 Jan 15; 38(1):33-9. PubMed ID: 5549166
    [No Abstract] [Full Text] [Related]

  • 18. [Clinical trial of L2214 in the treatment of gout or of rheumatologic syndromes associated with hyperuricemia].
    van Bogaert P.
    J Belge Rhumatol Med Phys; 1969 Jan 15; 24(6):295-315. PubMed ID: 5403086
    [No Abstract] [Full Text] [Related]

  • 19. [Hyperuricemia and benziodarone].
    Haddad N, Zamouri A, Naccache S.
    Tunis Med; 1973 Jan 15; 51(2):103-4. PubMed ID: 4784400
    [No Abstract] [Full Text] [Related]

  • 20. [Hyperuricemia due to diuretics in hypertensive patients. Curative treatment with benziodarone].
    Lagrue G, Menard J, Safar M, Schlotterer P, Milliez P.
    Presse Med (1893); 1971 Apr 17; 79(19):849-52. PubMed ID: 5576496
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.